• Johnson & Johnson plans to buy Shockwave Medical, according to the Wall Street Journal.
  • Apple holds its next Worldwide Developers Conference in June.
  • International Paper considers $6.3 billion bid for DS Smith.
  • UBS transfers Credit Suisse securitized loans to Apollo.
  • MicroStrategy launches a customizable artificial intelligence robot.
  • Tod's shareholder Tabor Asset Management asks L Catterton to raise its takeover offer.
  • UniCredit and Nexi agree on the general principles for renegotiating their existing agreement, according to Il Sole 24 Ore newspaper.
  • Hennes & Mauritz sees first-quarter profit jump but sales fall.
  • Roche obtains the green light from the FDA to market its diagnostic tool for malaria in blood donors.
  • Orsted receives green light from US authorities for 924 MW offshore wind project.
  • Solvay places a €1.5 billion bond issue in two tranches.
  • Trump Media & Technology, the media company owned by former US President Donald Trump, is up 11% in pre-market trading, a day after its dazzling debut on the Nasdaq.
  • Merck & Co climbed 4.5% as the FDA, the US health authority, approves its Winrevair treatment for adults suffering from pulmonary arterial hypertension, a condition that affects around 40,000 people in the country.
  • Amazon on Wednesday saw its request to suspend its obligation to make an advertising register available to the public rejected by the European Court of Justice, the bloc's highest court declaring that the interests of the EU should take precedence over the material interests of the American group.
  • Robinhood Markets jumped more than 7% after the online trading platform launched a new credit card on Tuesday evening, with the aim of expanding its presence in the personal finance market and increasing its subscriptions.
  • Gamestop plunged more than 18% after the group reported fourth-quarter sales well below those for the same period a year ago. The video game distributor also announced that it had cut jobs, without specifying the number, in order to control costs.
  • Moderna announced on Wednesday that it had reached an agreement with Blackstone's life sciences investment platform for $750 million in funding to develop its messenger RNA-based flu vaccines.
  • Citigroup laid off at least 10 people in its Asia-Pacific equity research department this week, two sources close to the matter reported, as the bank enters the final phase of a major restructuring plan.
  • Phillips 66 - The oil refining group is considering selling its 25% stake in the Rockies Express Pipeline for more than $1 billion, including debt, sources familiar with the matter reported Tuesday evening.